Neuroprotective Effect of a CNTF-Expressing Lentiviral Vector in the Quinolinic Acid Rat Model of Huntington's Disease

Neuroprotective Effect of a CNTF-Expressing Lentiviral Vector in the Quinolinic Acid Rat Model of Huntington's Disease

Neurodegenerative diseases represent promising targets for gene therapy approaches provided effective transfer vectors. In the present study, we evaluated the effectiveness of LacZ-expressing lentiviral vectors with two different internal promoters, the mouse phosphoglycerate kinase 1 (PGK) and cyto...

Full description

Bibliographic Details
Main Authors:	L.Pereira de Almeida, D. Zala, P. Aebischer, N. Déglon
Format:	Article
Language:	English
Published:	Elsevier 2001-06-01
Series:	Neurobiology of Disease
Subjects:	Huntington's disease lentiviral vector gene therapy ciliary neurotrophic factor quinolinic acid lesion model
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996101903882

Similar Items

Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1G93A transgenic mice
by: Sandrine Guillot, et al.
Published: (2004-06-01)

Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease
by: C. Lo Bianco, et al.
Published: (2004-11-01)

Expression of the neuroprotective factors BDNF, CNTF, and FGF-2 in normal and oxygen induced retinopathy
by: Jifu Xin, et al.
Published: (2022-12-01)

Long-Term Labeling of Hippocampal Neural Stem Cells by a Lentiviral Vector
by: Hoonkyo Suh, et al.
Published: (2018-11-01)

Advances of Lentiviral Vectors
by: Fanrong MENG, et al.
Published: (2014-12-01)

Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing
by: Michelle Yen Tran, et al.
Published: (2022-06-01)

Use of Integrase-Minus Lentiviral Vector for Transient Expression
by: Hossein Azadeh, et al.
Published: (2012-01-01)

Lentiviral Vector Bioprocessing
by: Christopher Perry, et al.
Published: (2021-02-01)

Protective effects of ciliary neurotrophic factor on the retinal ganglion cells by injure of hydrogen peroxide
by: Wen-Jun Wang, et al.
Published: (2018-06-01)

Lentiviral Vectors as Tools for the Study and Treatment of Glioblastoma
by: Claudia Del Vecchio, et al.
Published: (2019-03-01)

The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology
by: Luis Apolonia
Published: (2020-09-01)

Tagging and Capturing of Lentiviral Vectors Using Short RNAs
by: Martin Panigaj, et al.
Published: (2021-09-01)

Lentiviral delivery of Meteorin protects striatal neurons against excitotoxicity and reverses motor deficits in the quinolinic acid rat model
by: Jesper Roland Jørgensen, et al.
Published: (2011-01-01)

The Inside Out of Lentiviral Vectors
by: Stéphanie Durand, et al.
Published: (2011-02-01)

Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus
by: Alexis Duvergé, et al.
Published: (2020-11-01)

Toward Tightly Tuned Gene Expression Following Lentiviral Vector Transduction
by: Audrey Page, et al.
Published: (2020-12-01)

Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
by: Alessandra Gallinaro, et al.
Published: (2018-02-01)

Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges
by: Eduardo Martínez-Molina, et al.
Published: (2020-11-01)

Implementation of Novel Affinity Ligand for Lentiviral Vector Purification
by: Ana Sofia Moreira, et al.
Published: (2023-02-01)

Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives
by: Wendy Dong, et al.
Published: (2021-07-01)

Endogenous CNTF mediates stroke-induced adult CNS neurogenesis in mice
by: Seong Su Kang, et al.
Published: (2013-01-01)

Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
by: Negri Donatella RM, et al.
Published: (2012-08-01)

Gene Therapy Applications of Non-Human Lentiviral Vectors
by: Altar M. Munis
Published: (2020-09-01)

Lentiviral vector transduction of spermatozoa as a tool for the study of early development
by: Anil Chandrashekran, et al.
Published: (2014-01-01)

Lentiviral Vectors for Cancer Immunotherapy and Clinical Applications
by: David Escors, et al.
Published: (2013-07-01)

Minocycline in phenotypic models of Huntington's disease
by: Kadiombo Bantubungi, et al.
Published: (2005-02-01)

Lentiviral Vectors Delivered with Biomaterials as Therapeutics for Spinal Cord Injury
by: Ciara Shortiss, et al.
Published: (2021-08-01)

Gene therapy for Huntington's disease
by: Shilpa Ramaswamy, et al.
Published: (2012-11-01)

Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene Transfer
by: Nicole Cordes, et al.
Published: (2022-09-01)

Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes
by: Claudia Piovan, et al.
Published: (2017-06-01)

Physiological lentiviral vectors for the generation of improved CAR-T cells
by: María Tristán-Manzano, et al.
Published: (2022-06-01)

Long-term stability of clinical-grade lentiviral vectors for cell therapy
by: Julie K. Jadlowsky, et al.
Published: (2024-03-01)

Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through
by: Narmatha Gurumoorthy, et al.
Published: (2022-01-01)

Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?
by: Longfei Deng, et al.
Published: (2023-09-01)

The efficiency of use lentiviral vectors for the transformation of rooster spermatogenic cells in vivo
by: Natalya Alexandrovna Volkova, et al.
Published: (2019-12-01)

Construction of a CD147 Lentiviral Expression Vector and Establishment of Its Stably Transfected A549 Cell Line
by: Shaoxing YANG, et al.
Published: (2012-12-01)

Development of Large-Scale Downstream Processing for Lentiviral Vectors
by: Anniina J. Valkama, et al.
Published: (2020-06-01)

Bicistronic lentiviral vector corrects β-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts
by: Audrey Arfi, et al.
Published: (2005-11-01)

Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy
by: Valeria Morante, et al.
Published: (2021-02-01)

Integrase deficient lentiviral vector: prospects for safe clinical applications
by: Chee-Hong Takahiro Yew, et al.
Published: (2022-08-01)